Skip to Main Content

Paper Details

Exploiting induced vulnerability to overcome PARPi resistance and clonal heterogeneity in BRCA mutant triple-negative inflammatory breast cancer.
Am J Cancer Res
1
2022
BRCA mutant, BRCA mutant triple-negative inflammatory breast cancer, PARP, PARPi, PARPi-resistant clones, Ras, cancer, multiple, parental clone, resistant clones, transcriptomes, triple, triple-negative inflammatory breast cancer, triple-negative inflammatory breast cancer cell line, tumour
Author NameAffiliation
David J H ShihUniversity of Texas MD Anderson Cancer Center Houston
David J H ShihUniversity of Texas Health Science Center at Houston Houston
Daniel J McGrailUniversity of Texas MD Anderson Cancer Center Houston
Wenjin Jim ZhengUniversity of Texas Health Science Center at Houston Houston
Wenjin Jim ZhengUniversity of Texas Health Science Center at Houston Houston
Liuqing YangUniversity of Texas MD Anderson Cancer Center Houston
Mien-Chie HungChina Medical University Taichung 406040
Shiaw-Yih LinUniversity of Texas MD Anderson Cancer Center Houston
  • 1 - 8

Datasets

Release 1.2